22nd April 2020
We did it!
We built 2000 Flo-Ox™ devices in just 8 days, thereby securing the timely distribution of Flo-Ox™ oxygen monitors to hospitals and COVID-19 patients around the UK.
The Flo-Ox™ oxygen monitor was mandated by the MHRA to accompany the bedside roll-out of the recently announced UCL-Ventura CPAP breathing aid, conceived in response to an emergency COVID-19 call in the U.K.
Following an extraordinary effort by our design and engineering teams to go from clean sheet to viable design in just 2 weeks and an equally herculean effort by our numerous key suppliers (many of whom mobilizing furloughed employees) we were able to begin volume production of Flo-Ox™ on April 8th.
Having fundamentally re-tooled our production facilities, drafted in an additional temporary workforce of 33 individuals from the local community, implemented an 18-hour working day right through the Easter holiday and spurred on by a sense of pride to be supporting the UK’s health service at its time of need, we met our target production peak of 350 monitors per day with a total of just over 2000 monitors manufactured and delivered in all.
All while doing our very utmost to respect COVID-19 social distancing, hygiene and PPE recommendations to ensure the safety of all individuals involved.
Special mention and heartfelt gratitude to everyone working our aggressive shifts, to the numerous individuals who simply volunteered their time, to the long list of suppliers who pulled out all the stops to feed the ‘manufacturing machine’ and to our landlord MEPC who responded to our plea by providing overflow manufacturing floorspace at no cost, without which we could not have accommodated the numbers required while maintaining social distancing.
It has been a proud time for all of us at Oxford Optronix and we look forward to returning to a post-COVID ‘normality’ as soon and as safely as possible.
Meanwhile, a brief photographic record of 8 days of production unlike anything ever witnessed at Oxford Optronix:
2nd June 2020
22nd April 2020
Oxford Optronix builds 2000 Flo-Ox™ monitors in 8 days!
16th March 2020
Business continuity statement / COVID-19 pandemic
6th January 2020
Here comes 2020
11th April 2019
WellBeing™ clinical trials commence
5th February 2019
2nd January 2019
Happy New Year!
16th October 2017
Ed Vaizey MP visits Oxford Optronix
2nd June 2017
Welcome to our new website!
12th May 2017
Spring has sprung
1st December 2016
Reflecting on 2016; looking forward to 2017
1st October 2016
A little time Down Under…
1st April 2016
Latest GelCount software update
1st February 2016
Guest post by John Coyle, Business Development Principle
1st January 2016
Announcing a mutual distribution deal with Baker Ruskinn
1st December 2015
Asia distributor workshop
1st June 2015
Performance updates for HypoxyLab
1st March 2015
Meet us at Genes & Cancer UK, Cambridge
1st January 2015
Looking forward to a busy 2015
1st November 2014
Oxford Optronix reaches new customers
1st April 2014
Guest post by Michael Rau, Director of Sales
1st March 2014
Strategic tie-up with SciPro Inc., USA
1st February 2014
Single-channel OxyFlo™ now shipping
1st January 2014
GelCount™ software update
1st December 2013
Reflections on 2013
1st November 2013
Autumn conference round-up
1st October 2013
Our 2013 Customer Survey results are out
1st July 2013
Announcing our newly commissioned cleanroom
1st June 2013
A report on conferences attended in 2013 so far
1st February 2013
Next-generation OxyLite™ and OxyFlo™ monitors